The US Food and Drug Administration has approved desmopressin acetate, a nasal spray for adults who awaken at least two times per night to urinate due to a condition is known as nocturnal polyuria This is the first FDA-approved treatment for this condition. Nocturia (wakening at night to urinate) is a symptom that can be caused by a wide variety of conditions, such as congestive heart failure, poorly controlled diabetes mellitus, medications, or diseases of the bladder or prostate. FDA has approved the first therapeutic option for the patients who suffer nocturia.
However, it is important to know that desmopressin acetate nasal spray is not approved for all causes of night-time urination. As a result, a proper consultation with a doctor is must to determine the underlying cause of the night-time urination regarding this option as an appropriate choice. Efficacy of desmopressin acetate…
